Patient Experience Across Dental Implant Drilling Protocols
Comparative Analysis of Patient Experience Among Under-drilling and Conventional Drilling in Dental Implants: a Randomized Double-blinded Study.
The goal of this clinical trial is to learn whether the drilling technique used to prepare the implant site affects the experience and satisfaction of adult patients receiving dental implants. The main questions it aims to answer are:
- Do patients treated with under-drilling report a different experience, satisfaction and postoperative discomfort than patients treated with conventional drilling?
- How are implant insertion torque, implant stability and bone density related to the pain and experience reported by patients?
Researchers will compare under-drilling (the implant site is prepared with a slightly narrower final drill than usual) with conventional drilling (the standard drilling sequence for the implant diameter). Both are standard clinical techniques.
Participants will:
- Be randomly assigned to one of the two techniques, without knowing which one they receive
- Have their dental implant(s) placed at the CEU Cardenal Herrera University Dental Clinic
- Complete a questionnaire about their experience before surgery and immediately after surgery
- Record their experience every day during the first week after surgery
- Complete a quality-of-life questionnaire (OHIP-14) one week after surgery
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study design: Single-center, randomized, double-blind, parallel-group clinical trial with two arms (1:1 allocation). Although the ethics committee-approved protocol describes the study as a randomized double-blinded cohort observational study, participants are randomly allocated to one of two standard implant site preparation techniques; the study is therefore registered as interventional according to ClinicalTrials.gov definitions. No experimental products are used.
Randomization and blinding: A computer-generated random sequence, stratified by age and sex, will be prepared before the start of the study and kept concealed. The surgeon will be informed of the allocated technique only at the time of surgery. Participants and the statistician performing the data analysis will remain blinded to group allocation.
Surgical procedure: All procedures will be performed under local anesthesia (4% articaine with 1:100,000 epinephrine) using a crestal mucoperiosteal incision and saline irrigation. In both groups, the osteotomy starts with a lanceolate drill and a 2 mm pilot drill to the planned length. In the under-drilling group, the drilling sequence stops at the drill prior to the standard final drill for the implant diameter; in the conventional group, the manufacturer's standard sequence is completed. Nobel Biocare or 3i implants will be used. Insertion torque will be recorded with the surgical motor and implant stability (ISQ) will be measured after placement. Bone density will be classified according to Misch (D1-D4) using preoperative 3D imaging and intraoperative assessment.
Perioperative care (identical in both groups): 0.12% chlorhexidine mouthwash before and after surgery, antibiotic prophylaxis and postoperative antibiotic treatment (amoxicillin, or azithromycin in penicillin-allergic patients), dexketoprofen as anti-inflammatory, and paracetamol 1 g as rescue analgesic.
Data collection: Sociodemographic and anthropometric data (age, sex, education level, employment status, weight, height and medication use) will be recorded. Patient experience will be assessed with an 11-item visual analogue scale (0-100 mm) before surgery, immediately after surgery and daily during the first 7 postoperative days. Oral health-related quality of life will be assessed with the OHIP-14 at day 7.
Sample size: Based on an estimated standard deviation of 1.5 and a minimum clinically important difference of 1.17, with alpha = 0.05 and 80% power, 26 participants per group are required (52 in total). Allowing for losses, 62 participants will be enrolled.
Statistical analysis: Independent t-tests, Pearson's chi-square and Fisher's exact tests will be used, with a significance level of 5%.
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: RAQUEL GONZÁLEZ-MARTÍNEZ, DDS, MSc, PhD
- Phone Number: 0034961369000
- Email: raquel.gonzalez@uchceu.es
Study Contact Backup
- Name: GABRIELE MARZORATI, DDS
- Email: gabriele.marzorati1@uchceu.es
Study Locations
-
-
Valencia
-
Alfara del Patriarca, Valencia, Spain, 46115
- Clínica Odontológica Universitaria, Universidad CEU Cardenal Herrera
-
Contact:
- CRISTINA AGUEDA TOME
- Phone Number: +34 961369000
- Email: cristina.agueda@uchceu.es
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 18 years or older
- Partially or completely edentulous patients requiring dental implant placement
- Signed informed consent
Exclusion Criteria:
- Use of psychotropic or pain-modulating medication
- Systemic conditions affecting bone healing
- Use of medication known to interfere with bone metabolism
- Pregnancy or breastfeeding
- Allergy or intolerance to implant materials (e.g., titanium, zirconia)
- Severe bruxism or severe temporomandibular joint (TMJ) disorders
- Inability to follow postoperative care protocols or maintain basic oral hygiene
- Psychological or cognitive impairment that may interfere with understanding or following postoperative care instructions
- Inability to attend follow-up visits
- Previous implant failure
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Under-drilling (UD)
Participants receive dental implant(s) placed using the under-drilling technique. |
Implant site preparation with a lanceolate drill and a 2 mm pilot drill to the planned length, followed by the manufacturer's drilling sequence stopping at the drill prior to the standard final drill for the implant diameter, with saline irrigation. Nobel Biocare or 3i implants are placed and insertion torque is recorded. |
|
Active Comparator: Conventional drilling (CO)
Participants receive dental implant(s) placed using the conventional drilling technique. |
Implant site preparation with a lanceolate drill and a 2 mm pilot drill to the planned length, followed by the manufacturer's complete standard drilling sequence for the implant diameter, with saline irrigation. Nobel Biocare or 3i implants are placed and insertion torque is recorded. |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient Experience and Satisfaction (Visual Analogue Scale)
Time Frame: Preoperatively (baseline), immediately after surgery, and daily on postoperative days 1 to 7
|
Patient experience with the treatment assessed with an 11-item visual analogue scale (VAS). Each item is scored on a 100 mm line (0 = low, 50 = moderate, 100 = extreme). Higher scores indicate greater intensity of the assessed experience. |
Preoperatively (baseline), immediately after surgery, and daily on postoperative days 1 to 7
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Oral Health-Related Quality of Life (OHIP-14)
Time Frame: 7 days after surgery
|
Oral Health Impact Profile-14 questionnaire, covering 7 dimensions (functional limitation, physical pain, psychological discomfort, physical disability, psychological disability, social disability and handicap) with 2 items each. Total score range 0-56; higher scores indicate worse oral health-related quality of life. |
7 days after surgery
|
|
Implant Stability Quotient (ISQ)
Time Frame: During surgery (day 0)
|
Primary implant stability measured by resonance frequency analysis immediately after implant placement (ISQ units, 1-100; higher values indicate greater stability). |
During surgery (day 0)
|
|
Implant Survival
Time Frame: 7 days after surgery
|
Presence of the implant in situ without mobility, pain or signs of infection requiring removal. |
7 days after surgery
|
|
Implant Insertion Torque
Time Frame: During surgery (day 0)
|
Insertion torque (Ncm) recorded by the surgical motor (OsseoSet 300) at implant placement. |
During surgery (day 0)
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Bone Density (Misch Classification)
Time Frame: Preoperatively and during surgery (day 0)
|
Bone density at the implant site classified as D1-D4 according to Misch, assessed on preoperative 3D imaging and confirmed intraoperatively during drilling. |
Preoperatively and during surgery (day 0)
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: RAQUEL GONZÁLEZ-MARTÍNEZ, DDS, MSc, PhD, Cardenal Herrera University
- Principal Investigator: ISIDORO CORTELL-BALLESTER, MD, DDS, MSc, PhD, Cardenal Herrera University
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pain
- Neurologic Manifestations
- Musculoskeletal Diseases
- Mouth Diseases
- Stomatognathic Diseases
- Postoperative Complications
- Pathologic Processes
- Jaw Diseases
- Tooth Diseases
- Mouth, Edentulous
- Pathological Conditions, Signs and Symptoms
- Behavior
- Signs and Symptoms
- Treatment Adherence and Compliance
- Health Behavior
- Pain, Postoperative
- Jaw, Edentulous
- Patient Satisfaction
Other Study ID Numbers
Other Study ID Numbers
- CEEI25_699
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Individual participant data will not be shared. In accordance with the protocol approved by the ethics committee and with the EU General Data Protection Regulation (GDPR) and Spanish Organic Law 3/2018, access to the data is restricted to the research team, and the data will be destroyed after publication of the results.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.